Transforming growth factor-β3 protection of epithelial cells from cycle-selective chemotherapy in vitro
Authors:
- John D. HaleyJHJohn D. Haley
- 1 April 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (8) , 1149-1159
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interleukin‐11 protects the clonogenic stem cells in murine small‐intestinal crypts from impairment of their reproductive capacity by radiationInternational Journal of Cancer, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors.Gut, 1995
- Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.Journal of Experimental Medicine, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-βScience, 1993
- Differential Post-irradiation Caffeine Response in Normal Diploid versus SV40-transformed Human Fibroblasts: Potential Role of Nuclear Organization and Protein-compositionInternational Journal of Radiation Biology, 1993
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992
- Vascular Cell Responses to TGF-β 3 Mimic Those of TGF-β 1 in vitroGrowth Factors, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990